REAPPRAISAL OF SERUM β2-MICROGLOBULIN AS MARKER OF GFR

REFERENCES

• Creswell P, Springer T, Strominger J L, et al. Immunological identity of the small subunit of HLA antigensand β2-microglobulin and its turnover on the cell membrane. Proc Nat Acad Sci USA 1974; 71: 2123–2207
   PubMed Web of Science ®Google Scholar
• Berggård I, Bearn A G. Isolation and properties of low molecular weight β2-globulinoccurring in human biological fluids. J Biol Chem 1968; 243: 4095–4103
   PubMed Web of Science ®Google Scholar
• Nakamuro K, Tanigaki N, Pressman D. Multiple common properties of human β2-microglobulin andthe common portion fragment derived from HLA antigen molecules. Proc Nat Acad Sci USA 1973; 70: 2863–2865
   PubMed Web of Science ®Google Scholar
• Johnson V, Maak T. Renal tubular handling of proteins and peptides. Textbook of Nephrology, S G Massry, R J Glassock. 2nd ed, Williams and Wilkins, Baltimore 1989; 97–102
   Google Scholar
• Wibell L, Evrin P E, Berggård I. Serum β2-microglobulin in renal disease. Nephron 1973; 10: 320–331
   PubMed Web of Science ®Google Scholar
• Trollfors B, Norrby R. Estimation of glomerular filtration rate by serum creatinineand serum β2-microglobulin. Nephron 1981; 28: 196–199
   PubMed Web of Science ®Google Scholar
• Acchiardo S, Kraus A P, Jennings B R. β2-microglobulin levels in patients with renal insuficiency. Amer J Kid Dis 1989; 13: 70–74
   PubMed Web of Science ®Google Scholar
• Viberti G C, Keen H, Mackintosh D. Beta2-microglobulinaemia: a sensitive index of diminishing renalfunction in diabetics. British Medical J 1981; 282: 95–98
   PubMed Web of Science ®Google Scholar
• Shea P H, Maher J F, Horak E. Prediction of glomerular filtration rate by serum creatinineand β2-microglobulin. Nephron 1981; 29: 30–35
   PubMedGoogle Scholar
• Karlsson F A, Wibell L, Evrin P E. β2-microglobulin in clinical medicine. Scand J Clin Lab Invest 1980; 40: 27–37
   PubMedGoogle Scholar
• Mavligit G M, Stuckey S E, Cabanillas F F, et al. Diagnosis of leukemia or lymphoma in the central nervous systemby β2-microglobulin determination. New Eng J Med 1980; 303: 718–722
   PubMed Web of Science ®Google Scholar
• Brenning G, Wibell L, Bergström R. Serum β2-microglobulin at remission and relapse in patientswith multiple myeloma. Eur J Clin Invest 1985; 15: 242–247
   PubMed Web of Science ®Google Scholar
• Bianchi C. Noninvasive methods for the measurement of renal function. Renal Function Tests-Clinical Laboratory Procedures and Diagnosis, C G Duarte. Little, Brown and Company, Boston 1980; 65–84
   Google Scholar
• Bianchi C, Donadio C, Tramonti G, et al. A reappraisal of the bladder cumulative method as a reliabletechnique for the measurement of glomerular filtration rate. Renal Failure 1998; 20: 257–265
   PubMed Web of Science ®Google Scholar
• Bianchi C, Donadio C, Tramonti G, et al. A reappraisal of the bladder cumulative method as a reliabletechnique for the measurement of glomerular filtration rate. Renal Failure 1999; 21: 235–237, ERRATUM
   Google Scholar
• Cameron J S. Renal function testing. Oxford Textbook of Clinical Nephrology, S Cameron, A M Davison, J P Grünfeld, D Kerr, E. Ritz. OxfordUniversity Press, Oxford 1992; 24–49
   Google Scholar
• Lafayette R A, Perrone R D, Levey A S. Laboratory evaluation of renal function. Diseases of the Kidney, R W Schrier, C W Gottschalk. 6th ed, Little, Brown and Company, Boston 1997; 307–354
   Google Scholar
• Jones J D, Burnett P C. Creatinine metabolism in humans with decreased renal function:creatinine deficit. Clin Chem 1974; 20: 1204–1212
   PubMed Web of Science ®Google Scholar
• Mitch W E, Collier V U, Walser M. Creatinine metabolism in chronic renal failure. Clin Sc 1980; 58: 327–335
   PubMed Web of Science ®Google Scholar
• Shemesh O, Golbetz H, Kriss J P, Myers B D. Limitations of creatinine as a filtration marker in glomerulopathicpatients. Kidney Int 1985; 28: 830–838
   PubMed Web of Science ®Google Scholar
• Narayanan S, Appleton H D. Creatinine: a review. Clin Chem 1980; 26: 1119–1126
   PubMed Web of Science ®Google Scholar
• Weber J A, van Zanten A P. Interferences in current methods for measurements of creatinine. Clin Chem 1991; 37: 695–700
   PubMed Web of Science ®Google Scholar
• Horber F F, Scheidegger J, Frey F J. Overestimation of renal function in glucocorticosteroid treatedpatients. Eur J Clin Pharmacol 1985; 28: 537–541
   PubMed Web of Science ®Google Scholar
• Perrone R D, Madias N E, Levey A S. Serum creatinine as an index of renal function: new insightsinto old concepts. Clin Chem 1992; 38: 1933–1953
   PubMed Web of Science ®Google Scholar
• Kasise B L, Keane W F. Laboratory assessment of renal disease: clearance, urinalysis and renal biopsy. The Kidney, B M Brenner. 5th ed, WB Sanders Company, Philadelphia 1996; 1137–1174
   Google Scholar
• Carrie B J, Golbetz H V, Michaels A S, Myers B D. Creatinine: an inadequate filtration marker in glomerular disease. Am J Med 1980; 69: 177–182
   PubMed Web of Science ®Google Scholar
• Petri M, Bockenstedt L, Colman J, et al. Serial assessment of glomerular filtration rate in lupus nephropathy. Kidney Int 1988; 34: 832–839
   PubMed Web of Science ®Google Scholar
• Myers B D, Chagnac A, Golbetz H, et al. Extent of glomerular injury in active and resolving lupus nephritis:a theoretical analysis. Am J Physiol 1991; 260: F717–F727
   Google Scholar
• Viberti G C, Bilous R W, Mackintosh D, Keen H. Monitoring glomerular function in diabetic nephropathy. Am J Med 1983; 74: 256–264
   PubMed Web of Science ®Google Scholar
• Sturfelt G, Truedsson L, Thysell H, Björck L. Serum level of complement factor D in systemic lupus erythematosus– an indicator of glomerular filtration rate. Acta Med Scand 1984; 216: 171–177
   PubMedGoogle Scholar
• Grubb A, Simonsen O, Sturfelt G, et al. Serum concentration of cystatin C, factor D and β2-microglobulinas a measure of glomerular filtration rate. Acta Med Scand 1985; 218: 499–503
   PubMed Web of Science ®Google Scholar
• Kusano E, Suzuki M, Asano Y, et al. Human α1-microglobulin and its relationship to renal function. Nephron 1985; 41: 320–324
   PubMed Web of Science ®Google Scholar
• Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C (γ-trace)as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 1985; 45: 97–101
   PubMed Web of Science ®Google Scholar
• Tramonti G, Ferdeghini M, Donadio C, et al. Tumor-associated trypsin inhibitor (TATI) and renal function. Kidney Int 1997; 52: S179–S181
   Google Scholar
• Schardijn G HC, Statius van Eps L W. β2-microglobulin: its significance in the evaluation ofrenal function. Kidney Intl 1987; 32: 635–641
   PubMed Web of Science ®Google Scholar
• Filler G, Witt I, Priem F, et al. Are cystatin C and β2-microglobulin better markers thanserum creatinine for prediction of a normal glomerular filtration rate inpediatric subjects?. Clin Chem 1997; 43: 1077–1078
   PubMed Web of Science ®Google Scholar
• Hällgren R. Serum β2-microglobulin in liver disease. Scand J Clin Lab Invest 1979; 39: 441–447
   PubMed Web of Science ®Google Scholar
• de Jong P E, de Jong-van den Berg LTW, Sewrajsingh G S, et al. Beta-2-microglobulin in sickle cell anaemia – Evidenceof increased tubular reabsorption. Nephron 1981; 29: 138–141
   PubMedGoogle Scholar